We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Phaxiam Therapeutics | LSE:0QSS | London | Ordinary Share | FR001400K4B1 | PHAXIAM THERAPEUTICS ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 71.025 | 6.925 | 7.28 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1.33M | -23.49M | - | N/A | 0 |
From Feb 2024 to May 2024
Article 223-16 of general regulation of French Autorité des Marchés Financiers
Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) &
Nasdaq Global Select Market in the United-States (Symbol: PHXM)
Website : www.phaxiam.com
| Date | Total of shares composing the share capital | Total of brut (1) voting rights | Total of net (2) voting rights |
| December 31, 2023 | 6 075 105 | 6 226 982 | 6 226 733 |
| January 31, 2024 | 6 075 105 | 6 227 002 | 6 226 753 |
(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares.
Attachment
1 Year Phaxiam Therapeutics Chart |
1 Month Phaxiam Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
